Last updated on April 2019

Clinical Trial Assessing the Efficacy of Capsaicin Patch (Qutenza ) in Cancer Patients With Neuropathic Pain


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Neuralgia
  • Age: Between 18 - 100 Years
  • Gender: Male or Female

Inclusion Criteria:

  • Patient with at least 18 years old;
  • Patient presenting neuropathic pain secondary to an anti-cancerous treatment;
  • Patient presenting a DN4 (Neuropathic Pain in Four Questions) score superior or equal to 4 out of 10
  • Patient presenting a skin without lesion at the painful area
  • Informed consent form signed;
  • Patient affiliated to a social security scheme.

Exclusion Criteria:

  • Hypersensitivity known to capsaicin;
  • Instable or uncontrolled hypertension;
  • Painful area localised next to eyes;
  • Pregnant or breastfeeding woman;
  • Protected people.

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.